" /> 2-methylbutyryl-coa dehydrogenase deficiency - CISMeF





Preferred Label : 2-methylbutyryl-coa dehydrogenase deficiency;

CISMeF acronym : SBCADD;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : SBCADD; 2-methylbutyryl glycinuria; Short/branched-chain acyl-coa dehydrogenase deficiency;

Description : 2-Methylbutyryl-CoA dehydrogenase (MBD) deficiency is an autosomal recessive metabolic disorder of impaired isoleucine degradation. It is most often ascertained via newborn screening and is usually clinically asymptomatic, although some patients have been reported to have delayed development and neurologic signs. Therefore, the clinical relevance of the deficiency is unclear (Sass et al.., 2008).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the short/branched-chain acyl-CoA dehydrogenase gene (ACADSB, 600301.0001);

Laboratory abnormalities : Increased urinary 2-methylbutyrylglycine; Increased plasma 2-methylbutyrylcarnitine; Decreased short/branched-chain acyl-CoA dehydrogenase protein levels and enzyme activity;

Prefixed ID : #610006;

Details


You can consult :


Nous contacter.
02/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.